THE INVIVO FUNCTIONS AND PROPERTIES OF PERSISTING CELL-STIMULATING FACTOR
- 1 January 1984
- journal article
- research article
- Vol. 53 (1) , 33-42
Abstract
Persisting (P) cell-stimulating factor (PSF), a T cell lymphokine, apparently is produced and active in vivo. Mice injected in 1 footpad with keyhole limpet hemocyanin (KLH), or i.v. with sheep erythrocytes, had substantial increases in numbers of splenic P cell precursors; the increase following the sheep erythrocytes did not occur in athymic mice, implying a dependence on T lymphocytes. The increase in P cell precursors correlated with the local release of PSF; thus cells from the ipsilateral draining lymph node of mice injected in 1 footpad with KLH, but not cells from the contralateral node, showed both increased numbers of P cell precursors and the production of PSF. PSF could, in other situations, enter the circulation and exert effects distal to its release. Mice bearing a localized tumor that produced PSF (WEHI-3B), but not those bearing a non-producing subline, showed both a significant increase in P cell precursors in the spleen and bone marrow, and a marked increase in the numbers of mast cells, megakaryocytes, metamyelocytes and polymorphs in the spleen. PSF was detected in the serum of the mice bearing the PSF-producing tumor. Following i.v. injection of PSF into normal mice, there was a rapid initial clearance (t1/2 4 min), followed after 10 mins by a phase of slower clearance (t1/2 40 min). This was due to removal of PSF, rather than inhibition or destruction by serum factors; as when PSF was mixed in vitro with mouse serum for 24 h at 37.degree. C, no activity was lost.This publication has 21 references indexed in Scilit:
- Studies on the in vivo production of a lymphokine activity, interleukin 3 (IL-3) elaborated by lymphocytes and a myeloid leukaemic line in vitro and the fate of IL-3 dependent cell linesBritish Journal of Cancer, 1983
- Frequency of mast cell precursors in normal tissues determined by an in vitro assay: antigen induces parallel increases in the frequency of P cell precursors and mast cells.The Journal of Immunology, 1983
- Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity.The Journal of Immunology, 1983
- The fate of interleukin-2 after in vivo administration.The Journal of Immunology, 1983
- Bone marrow differentiation in vitro.1983
- In vitro andin vivo histamine-producing cell-stimulating factor (or IL3) production duringNippostrongylus brasiliensis infection: coincidence with self-cure phenomenonEuropean Journal of Immunology, 1983
- Procedures for the purification of interleukin 3 to homogeneity.The Journal of Immunology, 1982
- Clearance of interleukin 2 from the blood of normal and T cell‐depleted miceEuropean Journal of Immunology, 1982
- THE ULTRASTRUCTURE AND FUNCTION OF THE CELLS IN LYMPH FOLLOWING ANTIGENIC STIMULATIONThe Journal of Experimental Medicine, 1967
- THE LYMPH‐BORNE CELLS OF THE IMMUNE RESPONSEQuarterly Journal of Experimental Physiology and Cognate Medical Sciences, 1963